Achieve Life Sciences, Inc. Repayments of Convertible Debt
Achieve Life Sciences, Inc. (ACHV) reported Repayments of Convertible Debt of $18.11 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2026-03-24
- Achieve Life Sciences, Inc. repayments of convertible debt for the quarter ending 2024-12-31 was $0.00.
- Achieve Life Sciences, Inc. repayments of convertible debt for fiscal 2024 was $18.11M.
| Period end | Repayments of Convertible Debt 3 month | Repayments of Convertible Debt 9 month | Repayments of Convertible Debt 12 month |
|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $18.11M 10-K · filed 2026-03-24 | |
| 2024-09-30 | $18.11M 10-Q · filed 2025-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |